Tomohiko Yamane1,2, Atsushi Kondo3,4, Masafumi Takahashi3, Yuuki Miyazaki3, Toshihiko Ehara3, Kenji Koga3, Ichiei Kuji5, Ichiro Matsunari6. 1. Department of Nuclear Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, 350-1298, Japan. yamane_t@saitama-med.ac.jp. 2. Division of Nuclear Medicine, Department of Radiology, Saitama Medical University Hospital, 38 Moro-Hongo, Moroyama, 350-0495, Japan. yamane_t@saitama-med.ac.jp. 3. Department of Central Radiological Technology, Saitama Medical University Hospital, 38 Moro-Hongo, Moroyama, 350-0495, Japan. 4. Department of Radiological Technology, Graduate School of Health Science, Tokyo Metropolitan University, 7-2-10 Higashi-Oku, Arakawa-ku, Tokyo, 116-8551, Japan. 5. Department of Nuclear Medicine, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, 350-1298, Japan. 6. Division of Nuclear Medicine, Department of Radiology, Saitama Medical University Hospital, 38 Moro-Hongo, Moroyama, 350-0495, Japan.
Abstract
PURPOSE: To evaluate the feasibility of short whole-body bone scan acquisition times using a novel gamma camera with cadmium-zinc-telluride (CZT) semiconductor detectors. METHODS: We retrospectively enrolled 78 consecutive patients with prostate cancer who underwent bone scintigraphy using a whole-body gamma camera with CZT detectors. After acquisition of list-mode data with 180 s per bed position, anterior and posterior whole-body images were reconstructed using the first 5%, 10%, 25%, 50%, 75% and 100% of the list-mode data. Two experienced nuclear medicine physicians interpreted the images, and interrater agreement and the diagnostic value of the images were determined. Quantitative artificial neural network (ANN) values, bone scan indexes (BSI) and hotspot numbers (HsN) were also calculated by automated diagnostic software. RESULTS: Excellent interrater reliabilities of the visual assessments were obtained for the 100%, 75%, 50%, and 25% images (κ = 0.88, 0.88, 0.88 and 0.88, respectively). The 5% images also showed high diagnostic value (sensitivity 0.94, specificity 0.84 and accuracy 0.86). Intraclass correlation coefficients (ICC) between the 100% images and the reduced acquisition time images were evaluated in quantitative analyses, and excellent correlations were observed for ANN value in the 75% images (ICC 0.77), for BSI in all the reduced acquisition time images (75%, 50%, 25%, 10% and 5%; ICC 0.99, 0.99, 0.99, 0.96 and 0.75, respectively), and for HsN in the 75%, 50%, 25% and 10% images (ICC 0.99, 0.99, 0.98 and 0.90, respectively). CONCLUSION: Whole-body gamma cameras with CZT detectors have the potential to reduce image acquisition times and the dose of radioisotope injected for bone scans.
PURPOSE: To evaluate the feasibility of short whole-body bone scan acquisition times using a novel gamma camera with cadmium-zinc-telluride (CZT) semiconductor detectors. METHODS: We retrospectively enrolled 78 consecutive patients with prostate cancer who underwent bone scintigraphy using a whole-body gamma camera with CZT detectors. After acquisition of list-mode data with 180 s per bed position, anterior and posterior whole-body images were reconstructed using the first 5%, 10%, 25%, 50%, 75% and 100% of the list-mode data. Two experienced nuclear medicine physicians interpreted the images, and interrater agreement and the diagnostic value of the images were determined. Quantitative artificial neural network (ANN) values, bone scan indexes (BSI) and hotspot numbers (HsN) were also calculated by automated diagnostic software. RESULTS: Excellent interrater reliabilities of the visual assessments were obtained for the 100%, 75%, 50%, and 25% images (κ = 0.88, 0.88, 0.88 and 0.88, respectively). The 5% images also showed high diagnostic value (sensitivity 0.94, specificity 0.84 and accuracy 0.86). Intraclass correlation coefficients (ICC) between the 100% images and the reduced acquisition time images were evaluated in quantitative analyses, and excellent correlations were observed for ANN value in the 75% images (ICC 0.77), for BSI in all the reduced acquisition time images (75%, 50%, 25%, 10% and 5%; ICC 0.99, 0.99, 0.99, 0.96 and 0.75, respectively), and for HsN in the 75%, 50%, 25% and 10% images (ICC 0.99, 0.99, 0.98 and 0.90, respectively). CONCLUSION: Whole-body gamma cameras with CZT detectors have the potential to reduce image acquisition times and the dose of radioisotope injected for bone scans.
Entities:
Keywords:
Bone metastasis of prostate cancer; Bone scan; Cadmium-zinc-telluride (CZT); Gamma camera; Ultrafast scan
Authors: David Ulmert; Reza Kaboteh; Josef J Fox; Caroline Savage; Michael J Evans; Hans Lilja; Per-Anders Abrahamsson; Thomas Björk; Axel Gerdtsson; Anders Bjartell; Peter Gjertsson; Peter Höglund; Milan Lomsky; Mattias Ohlsson; Jens Richter; May Sadik; Michael J Morris; Howard I Scher; Karl Sjöstrand; Alice Yu; Madis Suurküla; Lars Edenbrandt; Steven M Larson Journal: Eur Urol Date: 2012-01-27 Impact factor: 20.096
Authors: Aseem Anand; Michael J Morris; Reza Kaboteh; Lena Båth; May Sadik; Peter Gjertsson; Milan Lomsky; Lars Edenbrandt; David Minarik; Anders Bjartell Journal: J Nucl Med Date: 2015-08-27 Impact factor: 10.057
Authors: Mohamed Mouden; Jorik R Timmer; Jan Paul Ottervanger; Stoffer Reiffers; Ad H J Oostdijk; Siert Knollema; Pieter L Jager Journal: Eur J Nucl Med Mol Imaging Date: 2012-03-17 Impact factor: 9.236
Authors: Elizabeth R Dennis; Xiaoyu Jia; Irina S Mezheritskiy; Ryan D Stephenson; Heiko Schoder; Josef J Fox; Glenn Heller; Howard I Scher; Steven M Larson; Michael J Morris Journal: J Clin Oncol Date: 2012-01-09 Impact factor: 44.544
Authors: Bernhard A Herzog; Ronny R Buechel; Ruth Katz; Michael Brueckner; Lars Husmann; Irene A Burger; Aju P Pazhenkottil; Ines Valenta; Oliver Gaemperli; Valerie Treyer; Philipp A Kaufmann Journal: J Nucl Med Date: 2009-12-15 Impact factor: 10.057
Authors: Ronny R Buechel; Bernhard A Herzog; Lars Husmann; Irene A Burger; Aju P Pazhenkottil; Valerie Treyer; Ines Valenta; Patrick von Schulthess; René Nkoulou; Christophe A Wyss; Philipp A Kaufmann Journal: Eur J Nucl Med Mol Imaging Date: 2010-01-27 Impact factor: 9.236